Healthcare Triangle, Inc. Signs Definitive Agreement with Teyame AI LLC which is forecasted to generate $38M in incremental NTM Revenue and incremental NTM EBITDA of $5M in addition to expanding its SaaS Footprint in Europe and Latin America

Core Viewpoint - Healthcare Triangle, Inc. (HCTI) is acquiring Teyame AI LLC and its subsidiaries, enhancing its position in AI-powered customer and patient engagement solutions, with a total consideration of approximately $50 million [1][2]. Financial Impact - The acquired assets generated approximately $32 million in incremental annual revenue and about $3.6 million in incremental EBITDA for fiscal year 2025, indicating a significant potential for enhancing HCTI's financial performance and shareholder value [2]. Strategic Importance - This acquisition marks a pivotal moment in HCTI's transition from a healthcare IT provider to a comprehensive digital innovator, aiming to create an integrated ecosystem that personalizes patient interactions [5][4]. Technological Integration - The integration of AI-powered engagement platforms with HCTI's healthcare technologies is expected to deliver a next-generation intelligent ecosystem for patients and providers, expanding HCTI's SaaS footprint into Europe and Latin America [4][5]. Innovation and Capabilities - The assets include advanced technologies such as chatbot automation, multilingual patient engagement tools, and real-time analytics, which will enhance HCTI's clinical systems and overall service offerings [8][11].